Wave Life Sciences is a biotechnology company dedicated to advancing RNA medicines for treating both rare and common diseases. Leveraging its PRISM® platform and diverse RNA-targeting modalities, including editing, splicing, RNA interference, and antisense silencing, the company develops innovative therapies for conditions such as Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency, Huntington's disease, and obesity. Driven by a commitment to 'Reimagine Possible,' Wave Life Sciences aims to unlock human potential by addressing the burden of disease.
Wave Life Sciences is a biotechnology company that focuses on unlocking the broad potential of RNA medicines to transform human health. The Associate Director, Clinical Supply role is responsible for strategic planning, execution, and oversight of end-to-end clinical trial material across Wave clinical studies.
Wave Life Sciences is a biotechnology company dedicated to advancing RNA medicines for treating both rare and common diseases. Leveraging its PRISM® platform and diverse RNA-targeting modalities, including editing, splicing, RNA interference, and antisense silencing, the company develops innovative therapies for conditions such as Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency, Huntington's disease, and obesity. Driven by a commitment to 'Reimagine Possible,' Wave Life Sciences aims to unlock human potential by addressing the burden of disease.
Revolution Medicines